Literature DB >> 8188575

Self-injury in Lesch-Nyhan disease.

L T Anderson1, M Ernst.   

Abstract

UNLABELLED: Parents of 40 patients with Lesch-Nyhan disease completed a questionnaire detailing developmental history, life course, management, medication, factors influencing variability and topography of self-injury. Several conclusions were reached. Characteristics: Biting was the predominant form, perhaps only because of the difficulty of preventing it. There was considerable variability in self-injury which was strongly related to stress rather than to operant influences. Even though patients could not inhibit self-injury they could predict it and request restraints. Aggression against others was as prevalent as self-injury. MANAGEMENT: Stress reduction, teeth extraction, and physical restraint were the most commonly used management techniques. Behavior modification was of limited efficacy. Benzodiazepines were the most commonly used medications for controlling self-injury. OUTCOME: The severity of self-injury did not change over years. Age of onset was a predictor of outcome. The earlier the age of onset the worse the self-injury eventually became. The discussion describes research strategies, suggests dimensions along which self-injury can be classified, and highlights behavior not commonly described in patients with Lesch-Nyhan disease.

Entities:  

Mesh:

Year:  1994        PMID: 8188575     DOI: 10.1007/bf02172213

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  10 in total

1.  Behavior in the Lesch--Nyhan syndrome.

Authors:  W L Nyhan
Journal:  J Autism Child Schizophr       Date:  1976-09

2.  A FAMILIAL DISORDER OF URIC ACID METABOLISM AND CENTRAL NERVOUS SYSTEM FUNCTION.

Authors:  M LESCH; W L NYHAN
Journal:  Am J Med       Date:  1964-04       Impact factor: 4.965

Review 3.  The Lesch-Nyhan syndrome.

Authors:  W L Nyhan
Journal:  Annu Rev Med       Date:  1973       Impact factor: 13.739

4.  Psychopharmacology of self-injurious behavior in the mentally retarded.

Authors:  J M Farber
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1987-05       Impact factor: 8.829

5.  Punishment learning and self-mutilation in Lesch-Nyhan disease.

Authors:  L Anderson; J Dancis; M Alpert; L Herrmann
Journal:  Nature       Date:  1977-02-03       Impact factor: 49.962

6.  Behavioral contingencies and self-mutilation in Lesch-Nyhan disease.

Authors:  L Anderson; J Dancis; M Alpert
Journal:  J Consult Clin Psychol       Date:  1978-06

7.  Cognitive abilities of patients with Lesch-Nyhan disease.

Authors:  L T Anderson; M Ernst; S V Davis
Journal:  J Autism Dev Disord       Date:  1992-06

8.  Enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis.

Authors:  J E Seegmiller; F M Rosenbloom; W N Kelley
Journal:  Science       Date:  1967-03-31       Impact factor: 47.728

9.  Monoamine oxidase activity decreased in cells lacking hypoxanthine phosphoribosyltransferase activity.

Authors:  X O Breakefield; C M Castiglione; S B Edelstein
Journal:  Science       Date:  1976-06-04       Impact factor: 47.728

10.  Behavior therapy for a child with Lesch-Nyhan syndrome.

Authors:  M Bull; F LaVecchio
Journal:  Dev Med Child Neurol       Date:  1978-06       Impact factor: 5.449

  10 in total
  23 in total

1.  Individual differences in vulnerability for self-injurious behavior: studies using an animal model.

Authors:  Amber M Muehlmann; Jennifer A Wilkinson; Darragh P Devine
Journal:  Behav Brain Res       Date:  2010-10-23       Impact factor: 3.332

2.  Effects of extended-release injectable naltrexone on self-injurious behavior in rhesus macaques (Macaca mulatta).

Authors:  Doty J Kempf; Kate C Baker; Margaret H Gilbert; James L Blanchard; Reginald L Dean; Daniel R Deaver; Rudolf P Bohm
Journal:  Comp Med       Date:  2012-06       Impact factor: 0.982

3.  Regional brain volume abnormalities in Lesch-Nyhan disease and its variants: a cross-sectional study.

Authors:  David J Schretlen; Mark Varvaris; Tiffany E Ho; Tracy D Vannorsdall; Barry Gordon; James C Harris; H A Jinnah
Journal:  Lancet Neurol       Date:  2013-12       Impact factor: 44.182

4.  Developmental and behavioural characteristics of cri du chat syndrome.

Authors:  K M Cornish; J Pigram
Journal:  Arch Dis Child       Date:  1996-11       Impact factor: 3.791

Review 5.  Multidisciplinary assessment and treatment of self-injurious behavior in autism spectrum disorder and intellectual disability: integration of psychological and biological theory and approach.

Authors:  Noha F Minshawi; Sarah Hurwitz; Danielle Morriss; Christopher J McDougle
Journal:  J Autism Dev Disord       Date:  2015-06

6.  Self-injurious behaviour: limbic dysregulation and stress effects in an animal model.

Authors:  A M Muehlmann; S D Kies; C A Turner; S Wolfman; M H Lewis; D P Devine
Journal:  J Intellect Disabil Res       Date:  2011-10-12

7.  Nifedipine suppresses self-injurious behaviors in animals.

Authors:  Bonita L Blake; Amber M Muehlmann; Kiyoshi Egami; George R Breese; Darragh P Devine; H A Jinnah
Journal:  Dev Neurosci       Date:  2006-10-17       Impact factor: 2.984

8.  Clinical severity in Lesch-Nyhan disease: the role of residual enzyme and compensatory pathways.

Authors:  Rong Fu; Diane Sutcliffe; Hong Zhao; Xinyi Huang; David J Schretlen; Steve Benkovic; H A Jinnah
Journal:  Mol Genet Metab       Date:  2014-11-08       Impact factor: 4.797

Review 9.  Attenuated variants of Lesch-Nyhan disease.

Authors:  H A Jinnah; Irene Ceballos-Picot; Rosa J Torres; Jasper E Visser; David J Schretlen; Alfonso Verdu; Laura E Laróvere; Chung-Jen Chen; Antonello Cossu; Chien-Hui Wu; Radhika Sampat; Shun-Jen Chang; Raquel Dodelson de Kremer; William Nyhan; James C Harris; Stephen G Reich; Juan G Puig
Journal:  Brain       Date:  2010-02-22       Impact factor: 13.501

10.  Non-suicidal self-injurious behavior, endogenous opioids and monoamine neurotransmitters.

Authors:  Barbara Stanley; Leo Sher; Scott Wilson; Rolf Ekman; Yung-yu Huang; J John Mann
Journal:  J Affect Disord       Date:  2009-11-25       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.